|2011||The inaugural issue is released. JPM is published as a quarterly journal.
The first Special Issue “Recent Advances in Personalized Medicine” is announced.
|2013||JPM is indexed in Scopus/SciVerse.|
|2014||JPM is indexed in PubMed and PubMed Central (PMC).|
|2016||JPM starts the Travel Awards project.|
|2018||JPM is covered by the Emerging Sources Citation Index, and receives its CiteScore™ metrics of 2.62, which equals rank 54/189 (Q1) in 'Medicine (miscellaneous)'.|
|2019||Journal of Personalized Medicine is accepted into SCIE as it is identified as a high performer, ranking in Q1.|
|2020||JPM receives its First Impact Factor of 4.433 (Journal Citation Report, 2019 Edition). JPM now ranks 10/102(Q1) in the category "Health Care Sciences & Services", 24/165(Q1) in the category "Medicine, General & Internal".|
|2021||JPM becomes a Monthly Publication.
The 2020 Impact Factor is 4.945. JPM now ranks 15/108(Q1) in the category " Health Care Sciences & Services", 31/169(Q1) in the category "Medicine, General & Internal".
Prof. Dr. David Alan Rizzieri accepted the role of Editor-in-Chief of JPM.
|2011–2015||Founding Editor-in-Chief: Prof. Dr. Urs A. Meyer|
|2015–2021||Editor-in-Chief: Prof. Dr. Stephen B. Liggett|
|2021–present||Editor-in-Chief: Prof. Dr. David Alan Rizzieri|
|2021–present||Section Editor-in-Chief: Prof. Dr. Enrico Mini for the section on Pharmacogenetics
Section Editor-in-Chief: Prof. Dr. Richard E. Frye for the section on Mechanisms of Diseases
Section Editor-in-Chief: Prof. Dr. Kenneth P.H. Pritzker for the section on Clinical Medicine, Cell, and Organism Physiology
Section Editor-in-Chief: Prof. Dr. K. Ray Chaudhuri for the section on Methodology, Drug and Device Discovery
|2022–present||Section Editor-in-Chief: Prof. Dr. Salvatore Scacco for the section on Omics/Informatics
Section Editor-in-Chief: Prof. Dr. Marijn Speeckaert for the section on Epidemiology